Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ECRI Institute names top 10 medtech hazards

This article was originally published in The Gray Sheet

Executive Summary

Widespread failure to follow established cleaning and sterilization guidelines during reprocessing helped place "cross-contamination from flexible endoscopes" at the head of ECRI's list of the 2010 Top 10 Technology Hazards, released Dec. 2 by the nonprofit research group. "The best defense against endoscopy-related cross-contamination continues to be careful development of and strict adherence to comprehensive, model-specific reprocessing protocols," ECRI writes. Alarm hazards come in second on the list, and can be minimized if hospitals look for designs that limit nuisance alarms, which can desensitize staff, "possibly leading them to ignore true hazards," the report advises. Other top 10 hazards for health care providers to monitor include surgical fires; radiation from computed tomography, which the report suggests could be responsible for 6,000 additional cancers each year; devices or fragments left in patients following surgery; needlesticks or other sharps injuries; data communication errors with computerized equipment and systems; surgical stapler hazards; and ferromagnetic objects that can become magnetized in a magnetic resonance imaging environment

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028242

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel